Home > Boards > US Listed > Biotechs >

Rexahn Pharmaceuticals, Inc. (RNN)

Add RNN Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator bud_fox
Search This Board:
Last Post: 7/23/2014 9:20:18 AM - Followers: 190 - Board type: Free - Posts Today: 0





Rexahn’s goal is to be a world leader in the discovery and development of new drugs to treat cancer. By developing compounds which specifically target cancer cells, excluding healthy tissue, Rexahn’s drug candidates may demonstrate increased efficacy and reduced toxicity- efficacy against multiple drug resistant cancer cells and synergism with existing cytotoxic compounds. Utilizing a powerful, multi-faceted discovery engine consisting of small signaling molecule discovery, computational modeling, nanotechnology-based drug targeting and delivery, we believe that we are well on our way to achieving our goal.

Rexahn’s core scientific expertise in the understanding of signal transduction processes involved in cancer cell growth is producing a drug portfolio with significant potential clinical value.

Today, our clinical development pipeline consists of three novel compounds:

Archexin® (Phase IIa) a best-in-class compound that blocks both the activated and native forms of Akt1 and has FDA orphan drug designation for the treatment of pancreatic cancer, ovarian cancer, stomach cancer, RCC, and glioblastoma.

RX-3117 (Phase I) a best-in-class compound that inhibits DNA and RNA synthesis, and exhibits high oral bioavailability. In comparison, RX-3117 may have a better safety profile than gemcitabine, the current first-line therapy for pancreatic and other cancers.

SupinoxinTM (RX-5902) (Phase I) a first-in-class small molecule that inhibits the phosphorylated p68 RNA helicase, a protein that plays a key role in cancer growth, progression and metastasis.

These lead clinical drugs are part of a growing oncology drug pipeline that consists of highly differentiated and exciting anti-cancer compounds.

Our strategy is to continue building a significant product pipeline of innovative medicines that we will commercialize on our own or with other pharmaceutical partners. Rexahn’s powerful discovery engine and differentiated product pipeline provide the opportunity for a high value generating biopharmaceutical company- one with the expertise to develop cures for significant diseases of our time.

Rexahn Pipeline


Management Team

Peter Suzdak, Ph.D.
Chief Executive Officer

Dr. Peter Suzdak joined Rexahn Pharmaceuticals in February 2013. Dr. Suzdak has over 25 years of diverse experience, including several management positions, in the pharmaceutical industry. Most recently, Dr. Suzdak was Chief Scientific Officer of Corridor Pharmaceuticals, a company developing small molecule compounds to treat pulmonary and vascular disorders. Prior to Corridor Pharmacueitcals, he was co-Founder, Chief Executive Officer and Chief Scientific Officer of Cardioxyl Pharmaceuticals, a company focused on therapies for the treatment of cardiovascular disease. Previous to Cardioxyl Pharmaceuticals, he was President and Chief Executive Officer of Artesian Therapeutics, a company engaged in the development of small molecule therapeutics for cardiovascular diseases. Dr. Suzdak’s experience also includes his position as Senior Vice President of Research and Development of Guilford Pharmaceuticals, a company that developed therapeutics and diagnostics for neurological diseases and cancer, and as Director of Neurobiology for Novo Nordisk. Dr. Suzdak holds a Ph.D. in pharmacology and toxicology from the University of Connecticut.

Rick Soni, MBA
President and Chief Operating Officer

Rick Soni joined Rexahn in 2008 with over 20 years of sales, marketing, product planning and business development experience in the pharmaceutical industry. Prior to joining Rexahn, Mr. Soni held leadership roles at Otsuka America Pharmaceuticals, Inc., with responsibility for commercial development, corporate strategy and execution of licensing and acquisition of therapeutics, diagnostics and medical devices. Previously, Mr. Soni has held a variety of management positions at Novartis and Schering-Plough. Mr. Soni has a BS from the University of Wisconsin-Madison and an MBA from Fairleigh Dickinson University.

Tae Heum (Ted) Jeong, D. Mgt.
Sr. Vice President  and Chief Financial Officer

Dr. Jeong has been Chief Financial Officer of Rexahn Pharmaceuticals since 2002. He oversees all aspects of capital raising, accounting, operations, and corporate development for Rexahn. He is also responsible for investor relations, and played a key role in Rexahn’s 2008 listing on the New York Stock Exchange (NYSE) AMEX. For the past 16 years, he has extensive experience in venture capital and investment banking industry that includes role at Hyundai Venture Investment Corporation where he managed the Biotechnology investment team. Dr. Jeong holds a Doctor of Management from University of Maryland and an M.S. in Finance from Johns Hopkins University

Roth Capital Partners, LLC
   Joseph Pantginis, Ph.D.


Maxim Group, LLC
Echo He, MD, Ph.D.


H. C. Wainwright & Co., LLC
Andrew Fein


Tricia Truehart
(646) 378-2953

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
RNN News: Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors 07/18/2014 09:00:00 AM
RNN News: Securities Registration Statement (simplified Form) (s-3/a) 06/18/2014 04:22:45 PM
RNN News: Statement of Changes in Beneficial Ownership (4) 06/16/2014 07:47:45 PM
RNN News: Statement of Changes in Beneficial Ownership (4) 06/11/2014 04:42:32 PM
RNN News: Statement of Changes in Beneficial Ownership (4) 06/11/2014 04:36:24 PM
#2689   really, GO RNN GO Spuds McKenz66 07/23/14 09:20:18 AM
#2688   Yes there is wish I had the ability klbennie 07/22/14 11:16:12 PM
#2687   big potential here RNN Spuds McKenz66 07/22/14 02:49:30 PM
#2686   Not me gotta see what happens. klbennie 07/21/14 10:53:09 PM
#2685   Everyone's running for the exit!! nathan2123 07/21/14 03:48:23 PM
#2684   No news on when and the ratio and EPak 07/20/14 01:25:55 PM
#2683   Has the split been finalized yet? Date thealias2002 07/19/14 07:53:17 AM
#2682   Sounds good to me. I will try that thanks klbennie 07/10/14 05:07:35 PM
#2681   I was given an advice that buy on EPak 07/10/14 10:19:34 AM
#2680   That stocks been a dog for while and EPak 07/10/14 10:18:06 AM
#2679   Thanks I am thinking the same. Been looking klbennie 07/10/14 10:12:47 AM
#2678   I hope it does because I will jump EPak 07/10/14 10:11:47 AM
#2677   Yeah I'm hoping for a turn around klbennie 07/10/14 10:09:19 AM
#2676   No, I don't like the fact that it EPak 07/10/14 10:08:18 AM
#2675   Sure don't seem that way though klbennie 07/10/14 10:05:09 AM
#2674   I am going to keep an eye for EPak 07/10/14 10:04:26 AM
#2673   I think I'm going to have to do klbennie 07/10/14 09:57:34 AM
#2672   I took a little lost and I am out. EPak 07/10/14 09:53:45 AM
#2671   That would be nice. We would all like klbennie 07/07/14 11:33:23 PM
#2670   I feel good about this company and hope EPak 07/07/14 07:26:45 PM
#2669   Yep, partnership PR soon! JDV57 07/07/14 06:48:22 PM
#2668   No nathan2123 07/07/14 06:27:06 PM
#2667   Is anyone following this stock? EPak 07/07/14 05:19:04 PM
#2666   Good morning, anyone here? EPak 07/07/14 10:56:48 AM
#2664   Ya you missed out on the APP run Crassus13 06/29/14 02:55:26 PM
#2663   Whenever they file with the sec. teifhals 06/26/14 01:57:45 AM
#2662   Anyone know when RS happening? Penguin3 06/26/14 12:48:24 AM
#2661   Holding my $ hostage and I'm missing out JDV57 06/25/14 10:17:14 PM
#2660   RNN going to be huge Spuds McKenz66 06/25/14 05:06:26 PM
#2659   Huge buy order just went thru nathan2123 06/25/14 10:28:06 AM
#2658   That's nice not many like the idea of nathan2123 06/20/14 06:01:12 PM
#2657   Oh 22:00 0,86 162 k sell Packardbell 06/20/14 05:02:50 PM
#2656   Great buying opportunity for the dip under .90c! 220v 06/18/14 01:27:25 PM
#2655   Must be why Zacks has a BIG sell PieceofPie 06/18/14 01:15:55 PM
#2654   getting bought up , going big time , Spuds McKenz66 06/17/14 11:28:25 AM
#2653   Proposal 4 – The proposal to approve an Spuds McKenz66 06/17/14 11:08:27 AM
#2652   Or 1 for 6 I think maybe the nathan2123 06/16/14 10:21:03 PM
#2651   Don't know that anybody does klbennie 06/16/14 10:20:28 PM
#2650   I guess the market doesn't like how they nathan2123 06/16/14 10:13:19 PM
#2649   Well yeah I seen that. Was looking for klbennie 06/14/14 05:23:33 PM
#2648   The stock went down....that's what happened... 220v 06/14/14 05:21:56 PM
#2647   What happened today? klbennie 06/13/14 07:55:49 PM
#2646   Do you plan on paying the maintenance call bud_fox 06/12/14 07:48:16 PM
#2645   RNN - Oh by the way - BOOOooooooOOOM!!! :) bud_fox 06/12/14 07:17:27 PM
#2643   Hell no teifhals 06/12/14 03:24:16 PM
#2642   Do you guys plan on selling with the R/S? DCholewa10 06/12/14 10:45:58 AM
#2641   You're a little late. They voted on boldcab 06/12/14 08:05:52 AM
#2640   Partnership "mid year" will trump and short term drop. JDV57 06/12/14 06:34:18 AM
#2639   Just a heads up for ppl here they nathan2123 06/12/14 12:15:01 AM
#2638   Nice...heading north again!! 220v 06/09/14 01:01:42 PM